金城医药：子公司参与集采药品接续采购拟中选

Core Viewpoint - Jincheng Pharmaceutical announced that its subsidiary, Guangdong Jincheng Jinsuo Pharmaceutical Co., Ltd., and its wholly-owned subsidiary, Shanghai Jincheng Suzhi Pharmaceutical Co., Ltd., participated in the bidding for the continuation procurement organized by the National Organization for the procurement of drugs whose agreements have expired [1] Group 1 - The company is involved in the bidding process for seven drug varieties, including Cefotaxime Sodium Injection and Ceftazidime Injection, as part of the national procurement program [1]